January 29, 2024 10:34 AM EST
News Briefing

As­cendis spins out oph­thal­mol­o­gy com­pa­ny; Gami­da Cell eyes strate­gic op­tions

Jaimy Lee

Deputy Editor

Plus, news about Skye Bio­science and Ve­ra Ther­a­peu­tics:

As­cendis Phar­ma, in­vestors spin out eye care com­pa­ny: Ey­co­nis, based in Red­wood City …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

FDA asks Covid vac­cine mak­ers to add more my­ocardi­tis da­ta to la­bels

Big leas­es, big­ger re­grets: Biotech slump turns swanky of­fices from as­set in­to li­a­bil­i­ty

Hinge Health is go­ing pub­lic on Thurs­day at a $3B val­u­a­tion

Al­tos Labs buys an­ti-ag­ing start­up Do­ri­an Ther­a­peu­tics

Up­dat­ed: Trump ad­min­is­tra­tion re­veals 'most fa­vored na­tion' drug price coun­try tar­gets

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times